# Take a quantum leap towards your next blockbuster

### There are no more low-hanging fruits in drug discovery
It’s time to use a taller ladder

### Pharmaceutical companies face significant challenges in drug discovery.
This includes high failure rates, rising R&D costs, and lengthy development cycles. We partner with computational teams at innovative drug companies to overcome these hurdles, uncovering new pathways to novel drug candidates in record speed and efficiency.

### Leap over the hurdles of conventional drug discovery
Our QuADD (Quantum-Aided Drug Design) solutions make it possible for computational chemistry teams to explore vast chemical spaces and optimize drug candidates in a fraction of the time required by conventional methods and tools.

[Learn More: QuADD vs. CADD](https://polarisqb.com/quantum-vs-traditional-screening/)

### Uncover novel and diverse hard-to-find molecules
All of our solutions integrate seamlessly into your discovery pipeline, allowing your team to apply your preferred discovery strategy.

- **Best-In-Class Mode:** Prioritize similarity to template structure.
- **First-In-Class Mode** Prioritize novelty.
- **Preferred-Library Mode:** Limit your search to your choice of commercial libraries.
- **Scaffold-Hopping Mode:** Hold part of the molecule constant while exploring other parts.

[Learn About QuADD Hits & Leads](https://polarisqb.com/hits-leads/)

### Apply to any protein target — no training data required
Unlike AI solutions that are constrained by available training data, our quantum-aided solutions use physics-based calculations — which can be used to identify and optimize drug candidates for any drug target with a known 3D structure, including those that are novel and less studied.

[Learn More: Quantum vs. AI](https://polarisqb.com/quantum-vs-ai/)

### Maintain explainability and confidence as you search uncharted spaces
Our QuADD solutions apply physics-based models that provide explainable output, delivering results that chemists can clearly understand and trust.

[Learn More: Quantum vs. CADD](https://polarisqb.com/quantum-vs-traditional-screening/)

### Supercharge your drug design pipeline with quantum computing power
###### QuADD   Rapid
1–5k top-quality lead-like molecules for your target protein pipeline, ready in two weeks

###### QuADD   Select
20–200 molecules optimized for your target protein, ready in 90 days for purchase or synthesis

###### QuADD   Collaborate
Joint development of best-fit molecules for new protein targets

### What our customers are saying

> “Our collaboration with PolarisQB led to rapid identification of viable drug candidates, significantly accelerating our research timeline towards quality solutions for hard to tackle or neglected diseases affecting women’s health.”  
> **Pek Lum, Ph.D.**, CEO, Auransa

> “Using quantum computing and advanced AI technology with PolarisQB, we explored a chemical space that was previously undefined, leading to the discovery of novel molecules for our primary program of Optimizing the Aging and Longevity Molecular Process much faster than expected.”  
> **Dr. Arthur Bollon**, President and Co-Founder, Allosteric Bioscience

> “This partnership represents the ultimate ambition for collaboration between biology and technology, where the full diversity of newly identified disease targets can be married to the most logical and rapid method of finding small molecule drugs.”  
> **Chris Torrance**, CEO, Phoremost

### The Quantum Age has arrived. Don’t get left behind.